In gliomas, Huillard et al. report significantly increased survival in mice transplanted with human V600E mutated astrocytoma cells when treated with the first generation BRAF inhibitor vemurafenib (PLX4720) (41). This evidence concerns the gene BRAF and central nervous system cancer.